Marco Tognetti

Years Active: 2022-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Attila Gabor, Marco Tognetti, Alice Driessen, Jovan Tanevski, Baosen Guo, Wencai Cao, He Shen, Thomas Yu, Verena Chung, null null, Bernd Bodenmiller, Julio Saez-Rodriguez
Cell-to-cell and type-to-type heterogeneity of signaling networks: insights from the crowd. Molecular systems biology 17 (10) (2022)
Lacey J Padrón, Deena M Maurer, Mark H O'Hara, Eileen M O'Reilly, Robert A Wolff, Zev A Wainberg, Andrew H Ko, George Fisher, Osama Rahma, Jaclyn P Lyman, Christopher R Cabanski, Jia Xin Yu, Shannon M Pfeiffer, Marko Spasic, Jingying Xu, Pier Federico Gherardini, Joyson Karakunnel, Rosemarie Mick, Cécile Alanio, Katelyn T Byrne, Travis J Hollman, Jonni S Moore, Derek D Jones, Marco Tognetti, Richard O Chen, Xiaodong Yang, Lisa Salvador, E John Wherry, Ute Dugan, Jill O'Donnell-Tormey, Lisa H Butterfield, Vanessa M Hubbard-Lucey, Ramy Ibrahim, Justin Fairchild, Samantha Bucktrout, Theresa M LaVallee, Robert A Anders
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial. Nature medicine 28 (6) (2022)
Marco Tognetti, Kamil Sklodowski, Sebastian Müller, Dominique Kamber, Jan Muntel, Roland Bruderer, Lukas Reiter
Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area. Journal of proteome research 21 (7) (2022)

Marco Tognetti.css-eqlu8i{font-size:small;padding-left:4px;}